Innovation of novel ‘Tab in Tab’ system for release modulation of milnacipran HCl: optimization, formulation and in vitro investigations
- 11 October 2012
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 39 (11) , 1851-1863
Abstract
The study was aimed toward development of modified release oral drug delivery system for highly water soluble drug, Milnacipran HCl (MH). Novel Tablet in Tablet system (TITs) comprising immediate and extended release dose of MH in different parts was fabricated. The outer shell was composed of admixture of MH, lactose and novel herbal disintegrant obtained from seeds of Lepidium sativum. In the inner core, MH was matrixed with blend of hydrophilic (Benecel®) and hydrophobic (Compritol®) polymers. 32 full factorial design and an artificial neuron network (ANN) were employed for correlating effect of independent variables on dependent variables. The TITs were characterized for pharmacopoeial specifications, in vitro drug release, SEM, drug release kinetics and FTIR study. The release pattern of MH from batch A10 containing 25.17% w/w Benecel® and 8.21% w/w of Compritol® exhibited drug release pattern close proximal to the ideal theoretical profile (t50% = 5.92 h, t75% = 11.9 h, t90% = 18.11 h). The phenomenon of drug release was further explained by concept of percolation and the role of Benecel® and Compritol® in drug release retardation was studied. The normalized error obtained from ANN was less, compared with the multiple regression analysis, and exhibits the higher accuracy in prediction. The results of short-term stability study revealed stable chataracteristics of TITs. SEM study of TITs at different dissolution time points confirmed both diffusion and erosion mechanisms to be operative during drug release from the batch A10. Novel TITs can be a succesful once a day delivery system for highly water soluble drugs.Keywords
This publication has 27 references indexed in Scilit:
- Challenges and New Technologies of Oral Controlled Release2010
- Design and Evaluation of Microporous Membrane Coated Matrix Tablets for a Highly Water Soluble DrugChemical and Pharmaceutical Bulletin, 2010
- Fabrication of Modified Release Tablet Formulation of Metoprolol Succinate using Hydroxypropyl Methylcellulose and Xanthan GumAAPS PharmSciTech, 2009
- Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofenAAPS PharmSciTech, 2007
- Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drugEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Hot-Melt Coating Technology. I. Influence of Compritol® 888 Ato and Granule Size on Theophylline ReleaseDrug Development and Industrial Pharmacy, 2000
- Formulation and Release Behavior of Diclofenac Sodium in Compritol 888 Matrix Beads Encapsulated in AlginateDrug Development and Industrial Pharmacy, 2000
- Pharmacokinetics of milnacipran in comparison with other antidepressantsInternational Clinical Psychopharmacology, 1996
- An Evaluation of the Mechanisms of Drug Release from Glyceride BasesJournal of Pharmacy and Pharmacology, 1995
- Controlled comparison of milnacipran and fluoxetine in major depressionPsychopharmacology, 1994